| scholarly article | Q13442814 |
| P50 | author | Ines Gomez-Acebo | Q50434947 |
| P2093 | author name string | Miguel A González-Gay | |
| Carlos Gonzalez-Juanatey | |||
| Javier Llorca | |||
| Ana Testa | |||
| Carlos Garcia-Porrua | |||
| Tomas R Vazquez-Rodriguez | |||
| Jose A Miranda-Filloy | |||
| Amalia Sanchez-Andrade | |||
| P2860 | cites work | Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy | Q82734935 |
| Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis | Q84185688 | ||
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Validated methods for assessment of subclinical atherosclerosis in rheumatology | Q34164481 | ||
| Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Q34315745 | ||
| High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis | Q36183213 | ||
| Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis | Q36204149 | ||
| Rheumatoid arthritis: a disease associated with accelerated atherogenesis | Q36220303 | ||
| Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register | Q36732112 | ||
| Systematic review and meta‐analysis: Anti–tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis | Q37801353 | ||
| HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis | Q42610707 | ||
| Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis | Q44187483 | ||
| Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis | Q45293503 | ||
| Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis | Q46075758 | ||
| Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody | Q47368581 | ||
| Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis. | Q47959078 | ||
| Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. | Q53725487 | ||
| Carotid Intima-Media Thickness Predicts the Development of Cardiovascular Events in Patients with Rheumatoid Arthritis | Q57307089 | ||
| The High Prevalence of Subclinical Atherosclerosis in Patients With Ankylosing Spondylitis Without Clinically Evident Cardiovascular Disease | Q57307093 | ||
| Endothelial Dysfunction, Carotid Intima-Media Thickness, and Accelerated Atherosclerosis in Rheumatoid Arthritis | Q57307097 | ||
| Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors | Q57307113 | ||
| High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors | Q57307115 | ||
| Effect of anti–tumor necrosis factor α therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis | Q57307126 | ||
| Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators | Q60692542 | ||
| HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis | Q61971712 | ||
| Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects | Q73628316 | ||
| Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients | Q79808209 | ||
| Short-term adalimumab therapy improves endo-thelial function in patients with rheumatoid arthritis refractory to infliximab | Q79996729 | ||
| Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis | Q80194544 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | endothelium | Q111140 |
| rheumatoid arthritis | Q187255 | ||
| adalimumab | Q348260 | ||
| TNF inhibitor | Q1536078 | ||
| P304 | page(s) | 674265 | |
| P577 | publication date | 2012-07-31 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy | |
| P478 | volume | 2012 |
| Q40474245 | Anti-Inflammatory Effects of TRAF-Interacting Protein in Rheumatoid Arthritis Fibroblast-Like Synoviocytes. |
| Q33902895 | Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis |
| Q30641972 | Association of serum angiopoietin-like protein 2 with carotid intima-media thickness in subjects with type 2 diabetes |
| Q38230867 | Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis |
| Q38185646 | Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q30240180 | Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease: a focus on rheumatoid arthritis. |
| Q37260123 | Effect of therapeutic inhibition of TNF on circulating endothelial progenitor cells in patients with rheumatoid arthritis. |
| Q38166661 | Effect of treating psoriasis on cardiovascular co-morbidities: focus on TNF inhibitors |
| Q35039228 | Indoline-3-propionate and 3-aminopropyl carbamates reduce lung injury and pro-inflammatory cytokines induced in mice by LPS |
| Q38181566 | Lipid profile changes in patients with rheumatic diseases receiving a treatment with TNF-α blockers: a meta-analysis of prospective studies |
| Q37358278 | Long-term treatment of rheumatoid arthritis with adalimumab |
| Q26822038 | Metabolic syndrome in rheumatoid arthritis |
| Q35673987 | Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis |
| Q34162072 | Modifications in lipid levels are independent of serum TNF-α in rheumatoid arthritis: results of an observational 24-week cohort study comparing patients receiving etanercept plus methotrexate or methotrexate as monotherapy |
| Q38121969 | Molecular hydrogen: new antioxidant and anti-inflammatory therapy for rheumatoid arthritis and related diseases |
| Q38612651 | Prevention of Stroke in Rheumatoid Arthritis |
| Q36088839 | Targeting Tumor Necrosis Factor-α with Adalimumab: Effects on Endothelial Activation and Monocyte Adhesion |
| Q38519523 | Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis. |
| Q50109832 | The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review |
| Q53095551 | The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis—a randomized, placebo-controlled pilot trial. |
| Q88979499 | Treat-to-target therapy does not prevent excessive progression of carotid intima media thickness during the first year of therapy in early rheumatoid arthritis |
Search more.